Researchers have made a significant breakthrough in understanding how oral cancer cells evade the body's immune system, leading to potential new...
Vous n'êtes pas connecté
Researchers from the University of Massachusetts Amherst and UMass Chan Medical School have made a significant breakthrough in treating pancreatic cancer. Their study, published in Science Translational Medicine, describes a new method that successfully shrinks and even clears tumors in mice. This innovative approach combines a novel drug-delivery system with immune-boosting agents to target and […]
Researchers have made a significant breakthrough in understanding how oral cancer cells evade the body's immune system, leading to potential new...
Researchers at Macquarie University have made a significant breakthrough in understanding how medlinkoral cancer/medlink cells evade the body's...
WashU Medicine researchers have designed, in mice, an approach to minimizing the damage from a spinal cord injury through the use of engineered immune...
WashU Medicine researchers have designed, in mice, an approach to minimizing the damage from a spinal cord injury through the use of engineered immune...
A team at Nagoya University Graduate School of Medicine has found that the enzyme protein kinase N (PKN) plays a role in cardiac fibrosis linked to...
A team at Nagoya University Graduate School of Medicine has found that the enzyme protein kinase N (PKN) plays a role in cardiac fibrosis linked to...
RNA nasal spray: A groundbreaking innovation in treating memory loss and anxiety, offering new hope for more effective and non-invasive therapies.
Breakthrough in triple-negative breast cancer diagnosis: New test improves early detection, offering better outcomes and personalized treatment...
VANCOUVER, British Columbia & NEW YORK — Integrated Nanotherapeutics (INT), a biotechnology company developing innovative treatments for...
VANCOUVER, British Columbia & NEW YORK — Integrated Nanotherapeutics (INT), a biotechnology company developing innovative treatments for...